Anti-Human/Mouse/Rat Alpha Smooth Muscle (αSM) Actin (1A4) – Purified No Carrier Protein

Anti-Human/Mouse/Rat Alpha Smooth Muscle (αSM) Actin (1A4) – Purified No Carrier Protein

Product No.: A460

- -
- -
Clone
1A4
Target
α-Smooth Muscle Actin (SMA)
Formats AvailableView All
Product Type
Monoclonal Antibody
Isotype
Mouse IgG2a k
Applications
FA
,
FC
,
IF
,
IHC
,
IHC FFPE
,
IP
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human/Mouse/Rat
Immunogen
N-terminal synthetic peptide corresponding to Human alpha smooth muscle actin.
Product Concentration
≥1.0 mg/ml
Purity
≥90% monomer by analytical SEC and SDS-Page
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
State of Matter
Liquid
Storage and Handling
This antibody may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory Status
Research Use Only
Country of Origin
USA
Shipping
2-8°C Wet Ice
Additional Applications Reported In Literature ?
FA
IHC
IF
IP
WB
FC
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Clone 1A4 activity is specific to alpha-smooth muscle actin (αSMA, SMA, smooth muscle aortic alpha‐actin (ACTA2)).
Background
Myofibroblasts are specialized connective tissue fibroblasts that use actin-based motors to generate contractile forces that are applied to extracellular matrix adhesion receptors 1. Alpha-smooth muscle actin (SMA) is a tissue specific actin isoform involved in myofibroblast differentiation, focal adhesion maturation, actin polymerization, tractional remodeling of the extracellular matrix, and the generation and transmission of mechanical forces in connective tissue, i.e., mechanotransduction. These physical forces are important for wound healing, joint and ligament remodeling due to injury or pregnancy, and the maintenance of tissue structure in the urinary bladder. SMA facilitates the generation of contractile forces in myofibroblasts and may contribute to scar formation and fibrocontractive diseases 1. Additionally, cancer-associated fibroblasts (CAF) play key roles in the tumor microenvironment, affecting tumor development, metabolism, and migration 2. SMA is highly expressed in CAFs and is widely used as a marker to identify CAF populations. However, SMA cannot be used for flow-sorting CAF populations for further functional studies because of its intracellular localization.

1A4 was produced using a synthetic decapeptide as immunogen, consisting of the NH2-terminal peptide of SMA coupled to BSA and a keyhole limpet hemocyanin (Ac-Glu(OBut)-Glu(OBut)-Glu(OBut)-Asp(OBut)-Ser(But)-Thr(But)-Ala-Leu-Val-Cys(Acm)-NHEt) 3. BALB/c mice were immunized and spleen cells were fused with Sp2/0 myeloma cells. Hybridomas were screened by ELISA against bovine aortic actin and further tested by immunofluorescence in chicken gizzard.
Antigen Distribution
Alpha-smooth muscle actin (SMA) is expressed by myofibroblasts and is the actin isoform typical of vascular smooth muscle cells. SMA is incorporated into stress fibers and focal adhesions and is also expressed by granulation tissue fibroblasts of healing wounds. Additionally, SMA expression is activated during the early stages of embryonic cardiovascular development. Astrocytes can also express SMA in culture. SMA is highly expressed in cancer-associated fibroblasts.
Ligand/Receptor
Myosins
NCBI Gene Bank ID
UniProt.org
Research Area
Cell Biology
.
Cell Motility/Cytoskeleton/Structure
.
Neuroscience

References & Citations

1. Wang J, Zohar R, McCulloch CA. Exp Cell Res. 312(3):205-214. 2006.
2. Nurmik M, Ullmann P, Rodriguez F, et al. Int J Cancer. 146(4):895-905. 2020.
3. Skalli O, Ropraz P, Trzeciak A, et al. J Cell Biol. 103(6 Pt 2):2787-2796. 1986.
4. Schürch W, Skalli O, Seemayer TA, et al. Am J Pathol. 128(1):91-103. 1987.
5. Rudy DE, Yatskievych TA, Antin PB, et al. Dev Dyn. 221(1):61-71. 2001.
6. Franke WW, Moll R. Differentiation. 36(2):145-163. 1987.
7. Chang CY, Chiou PP, Chen WJ, et al. Res Vet Sci. 88(2):285-293. 2010.
8. Lavaud S, Poirier B, Mandet C, et al. Am J Physiol Renal Physiol. 280(4):F683-694. 2001.
9. Li Y, Pan Z, Ji Y, et al. Eur Heart J. 23(7):567-573. 2002.
10. Cinel L, Düşmez D, Nabaei SH, et al. Acta Obstet Gynecol Scand.
FA
Flow Cytometry
IF
IHC
IHC FFPE
Immunoprecipitation Protocol
General Western Blot Protocol

Certificate of Analysis

Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.